Welby
4438
Value Creation
9238
Perseus Proteomics
4882
System Location
2480
Tokyo Radiator Mfg
7235
JP Stock MarketDetailed Quotes
4502 Takeda Pharmaceutical
- 4549.0
- +34.0+0.75%
20min DelayTrading Mar 19 13:26 JST
7.24TMarket Cap49.90P/E (Static)
4567.0High4519.0Low2.54MVolume4523.0Open4515.0Pre Close11.54BTurnover4567.052wk High0.17%Turnover Ratio1.59BShares3852.052wk Low129.68EPS TTM6.98TFloat Cap8080.0Historical High49.90P/E (Static)1.53BShs Float2894.5Historical Low91.16EPS LYR1.06%Amplitude192.00Dividend TTM0.97P/B100Lot Size4.22%Div YieldTTM
About Takeda Pharmaceutical Company
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Company Profile
Symbol4502
Company NameTakeda Pharmaceutical
Founded1925-01-29
MarketTSE Prime
Employees49281
Fiscal Year Ends03-31
Address1-1, Nihonbashi-Honcho 2-Chome Chuo-ku
Zip Code540-8645
Phone06-6204-2111
Websitewww.takeda.com
Company Executives
- Name
- Position
- Salary
- Akiko Amakawa
- Corporate Strategy Officer and Chief Executive Officer Chief of Staff
- --
- Christophe Weber
- Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
- 1.70B
- Mwana Lugogo
- Chief Ethics and Compliance Officer
- --
- Gabriele Ricci
- Chief Data and Technology Officer
- --
- Lauren Duprey
- Chief Human Resources Officer
- --
- Milano Furuta
- Director and Chief Financial Officer
- --
- Takako Ohyabu
- Chief Global Corporate Affairs and Sustainability Officer
- --
- Dr. Thomas Wozniewski, PhD
- Global Manufacturing and Supply Officer
- --
- Elaine Shannon
- Global Quality Officer
- --
- Marcello Agosti
- Global Business Development Officer
- --
- Masami Iijima
- Chairman of the Board
- 43.00M
- Ramona Sequeira
- President, Global Portfolio Division
- --
- Teresa Marie Bitetti
- President, Global Oncology Business Unit
- --
- Asuka Miyabashira
- President, Japan Pharma Business Unit
- --
- Andrew S. Plump, M.D.
- Director and President, Research and Development
- 12.00M
- Julie Kim
- President, U.S. Business Unit and U.S. Country Head
- --
- Giles Platford
- President, Plasma-Derived Therapies Business Unit
- --
- Dr. Steven Gillis, Pd.D
- Independent Director
- 44.00M
- Miki Tsusaka
- Independent Director
- 32.00M
- Ian T. Clark
- Independent Director
- 44.00M
- Yoshiaki Fujimori
- Independent Director
- 40.00M
- Koji Hatsukawa
- Independent Director
- 43.00M
- Dr. John M. Maraganore,PhD
- Independent Director
- 39.00M
- Kimberly A. Reed
- Independent Director
- 41.00M
- Emiko Higashi
- Independent Director
- 49.00M
- Jean-Luc Butel
- Independent Director
- 38.00M
- Michel Orsinger
- Independent Director
- 46.00M
- Yoshihiro Nakagawa
- Global General Counsel
- --